Legislative Services  |  Legislative Audits
Bill number does not exist. Enter a vaild keyword.
Facebook Twitter Youtube Channels
facebook twitter
Facebook Twitter
Click to add bill to MyMGA list

SB0793

Original
Chamber
1st
Reading
Referral
to Cmte
2nd
Reading
3rd
Reading
Opposite
Chamber
1st
Reading
Referral
to Cmte
2nd
Reading
3rd
Reading
Review in
Original Chamber
Passed Both
Chambers
Conf. Cmte
(if necessary)
To Governor
Title
Public Health - Opioid Overdose Reversal Drugs
Sponsored by
Senator Mautz
Status
In the Senate - First Reading Finance
Analysis
Fiscal and Policy Note
Synopsis
Requiring a licensed health care provider, when issuing a standing order for an opioid overdose reversal drug, to allow an individual to choose any formulation of any opioid overdose reversal drug approved by the federal Food and Drug Administration; and prohibiting certain private and public entities that prescribe and dispense opioid overdose reversal drugs from being required to keep in stock and dispense all opioid overdose reversal drugs approved by the federal Food and Drug Administration.
Committees
Original:
Finance
Details
Cross-filed with: HB0572
Introduced in a prior session as: SB0408 Session: 2024 Regular Session
Bill File Type: Regular
Effective Date(s): October 1, 2025
History
Legislation History
Chamber
Senate
Calendar Date
2/03/2025
Legislative Date
1/28/2025
Action
First Reading Finance
Proceedings
Chamber
Calendar Date
Legislative Date
Action
Text - First - Public Health - Opioid Overdose Reversal Drugs
Proceedings
Chamber Calendar Date Legislative Date Action Proceedings
Senate 2/03/2025 1/28/2025 First Reading Finance
Text - First - Public Health - Opioid Overdose Reversal Drugs
File Code
Subjects
Statutes
Last Updated: 2/4/2025 4:23 PM
Click to return on the top page